Conversely, SphK1 inhibition (by its inhibitors), silencing (using genetic measures), or loss-of-function of mutations shall lead to depleted S1P formation, while inducing accumulation of pro-apoptotic ceramide and sphingosine [9–12], eventually causing growth arrest and apoptosis in cancer cells [9–12]. Here, SPHK1 is linked to cancer.